These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8613046)

  • 1. Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial.
    Oren R; Arber N; Odes S; Moshkowitz M; Keter D; Pomeranz I; Ron Y; Reisfeld I; Broide E; Lavy A; Fich A; Eliakim R; Patz J; Bardan E; Villa Y; Gilat T
    Gastroenterology; 1996 May; 110(5):1416-21. PubMed ID: 8613046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
    Oren R; Moshkowitz M; Odes S; Becker S; Keter D; Pomeranz I; Shirin H; Reisfeld I; Broide E; Lavy A; Fich A; Eliakim R; Patz J; Villa Y; Arber N; Gilat T
    Am J Gastroenterol; 1997 Dec; 92(12):2203-9. PubMed ID: 9399753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
    Carbonnel F; Colombel JF; Filippi J; Katsanos KH; Peyrin-Biroulet L; Allez M; Nachury M; Novacek G; Danese S; Abitbol V; Bossa F; Moreau J; Bommelaer G; Bourreille A; Fumery M; Roblin X; Reinisch W; Bouhnik Y; Brixi H; Seksik P; Malamut G; Färkkilä M; Coulibaly B; Dewit O; Louis E; Deplanque D; Michetti P; Sarter H; Laharie D; ;
    Gastroenterology; 2016 Feb; 150(2):380-8.e4. PubMed ID: 26632520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
    Herfarth H; Barnes EL; Valentine JF; Hanson J; Higgins PDR; Isaacs KL; Jackson S; Osterman MT; Anton K; Ivanova A; Long MD; Martin C; Sandler RS; Abraham B; Cross RK; Dryden G; Fischer M; Harlan W; Levy C; McCabe R; Polyak S; Saha S; Williams E; Yajnik V; Serrano J; Sands BE; Lewis JD;
    Gastroenterology; 2018 Oct; 155(4):1098-1108.e9. PubMed ID: 29964043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006618. PubMed ID: 17943916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate for maintenance of remission in ulcerative colitis.
    El-Matary W; Vandermeer B; Griffiths AM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007560. PubMed ID: 19588435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.
    Paoluzi OA; Pica R; Marcheggiano A; Crispino P; Iacopini F; Iannoni C; Rivera M; Paoluzi P
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1751-9. PubMed ID: 12269968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):96-109.e1. PubMed ID: 23770005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral methotrexate in ulcerative colitis.
    Cummings JR; Herrlinger KR; Travis SP; Gorard DA; McIntyre AS; Jewell DP
    Aliment Pharmacol Ther; 2005 Feb; 21(4):385-9. PubMed ID: 15709988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in ulcerative colitis: a nationwide retrospective cohort from the Veterans Affairs Health Care System.
    Khan N; Abbas AM; Moehlen M; Balart L
    Inflamm Bowel Dis; 2013 Jun; 19(7):1379-83. PubMed ID: 23542534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; van Assche G; Reinisch W; Colombel JF; D'Haens G; Wolf DC; Kron M; Tighe MB; Lazar A; Thakkar RB
    Gastroenterology; 2012 Feb; 142(2):257-65.e1-3. PubMed ID: 22062358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.
    Ogata H; Kato J; Hirai F; Hida N; Matsui T; Matsumoto T; Koyanagi K; Hibi T
    Inflamm Bowel Dis; 2012 May; 18(5):803-8. PubMed ID: 21887732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis.
    Hawkey CJ; Dube LM; Rountree LV; Linnen PJ; Lancaster JF
    Gastroenterology; 1997 Mar; 112(3):718-24. PubMed ID: 9041232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
    Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T;
    Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
    Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
    J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial.
    Tamaki H; Nakase H; Inoue S; Kawanami C; Itani T; Ohana M; Kusaka T; Uose S; Hisatsune H; Tojo M; Noda T; Arasawa S; Izuta M; Kubo A; Ogawa C; Matsunaka T; Shibatouge M
    Dig Endosc; 2016 Jan; 28(1):67-74. PubMed ID: 26418574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.